ESC 365 - Endothelial dysfunction due to decreased nitric oxide bioavailability in dysglycaemic subjects and first-degree relatives of type 2 diabetic patients

ESC Professional Premium Access

Endothelial dysfunction due to decreased nitric oxide bioavailability in dysglycaemic subjects and first-degree relatives of type 2 diabetic patients

Session: Diabetes and the heart 1

Topic: Metabolic Syndrome, Insulin, Insulin Resistance

Speaker: Doctor I. Ikonomidis (Athens, GR)

Event: ESC Congress 2022

Congress Presentation

Add to my library

About the speaker

Doctor Ignatios Ikonomidis

National & Kapodistrian University of Athens, Athens (Greece)

5 presentations

3 followers

4 more presentations in this session

Diabetes and coronary risk equivalency - a population-based cohort study from Western Denmark

Speaker: Doctor K. Olesen (Aarhus, DK)

Measures of insulin resistance as a screening tool for dysglycaemia in patients with coronary artery disease. A report from the EUROASPIRE V population.

Speaker: Doctor G. Ferrannini (Stockholm, SE)

Quantity of adipose tissue and adipose tissue dysfunction and the risk of cancer in individuals at high risk of cardiovascular disease

Speaker: Ms M. Helmink (Utrecht, NL)

Metabolic syndrome and heart failure: 40 years follow up results of the Seven Countries Study

Speaker: Assistant Professor B. Parapid (Belgrade, RS)

Access the full session

Diabetes and the heart 1

Speakers: Doctor I. Ikonomidis, Doctor K. Olesen, Doctor G. Ferrannini, Ms M. Helmink, Assistant Professor B. Parapid

About the event

ESC Congress 2022

26 August - 29 August 2022

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources